Search

Displaying results 9881 - 9890 of 10000 in total
  1. Drug

    BCL-005

    go.drugbank.com/drugs/DB17242
    Experimental

    BCL-005 is a product formed by fused (hybrid) melanoma-dendritic cells.

  2. Drug

    ISB 1342

    go.drugbank.com/drugs/DB17251
    Investigational

    ISB 1342 is a bispecific antibody simultaneously targeting CD38 and CD3.

  3. Drug

    Etentamig

    go.drugbank.com/drugs/DB17268
    Investigational

    TNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.

  4. Drug

    Cirtuvivint

    go.drugbank.com/drugs/DB17269
    Investigational

    Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.

  5. Drug

    Disufenton

    go.drugbank.com/drugs/DB17298
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Trimethyltetradecylammonium

    go.drugbank.com/drugs/DB17342
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Ocaratuzumab

    go.drugbank.com/drugs/DB17359
    Investigational

    Ocaratuzumab is a humanized monoclonal antibody directed against CD20. It is being investigated for cancers and autoimmune disorders.

    Synonyms: Immunoglobulin G1, anti-(human B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1, Bp35, leukocyte surface antigen Leu-16, membrane-spanning 4-domains subfamily A member 1))
  8. Drug

    LioCyx-M004

    go.drugbank.com/drugs/DB17368
    Investigational

    LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.

  9. Drug

    Zanolimumab

    go.drugbank.com/drugs/DB17376
    Investigational

    Zanolimumab is a fully human monoclonal antibody directed against CD4.

  10. Drug

    TNG908

    go.drugbank.com/drugs/DB17411
    Investigational

    TNG908 is a small molecule inhibitor of protein arginine methyl transferase 5 (PRMT5).